TY - JOUR T1 - Distance practical course on systematic reviews to support decisions of Brazilian regulatory agency for supplementary healthcare system JF - BMJ Evidence-Based Medicine JO - BMJ EBM DO - 10.1136/bmjebm-2020-111617 SP - bmjebm-2020-111617 AU - Rafael Leite Pacheco AU - Angela Maria Bagattini AU - Daniela Vianna Pachito AU - Ana Luiza Cabrera Martimbianco AU - Fernanda d Athayde Rodrigues AU - Roberta de Fátima Carreira Moreira AU - Rachel Riera Y1 - 2021/01/11 UR - http://ebm.bmj.com/content/early/2021/01/11/bmjebm-2020-111617.abstract N2 - The healthcare service in Brazil comprises a public and universal system (Sistema Único de Saúde, SUS), but a considerable part of the population (59.7 million) also maintains a private health insurance as a supplementary care.1 The supplementary system is regulated by an autonomous governmental agency, formally Agência Nacional de Saúde Suplementar (ANS), which regulates the relationship between users and health operators and plans, including financial, legal and coverage aspects.The catalogue of drugs, devices and procedures that should be offered by health plans to their users is updated by ANS every other year for adding, replacing or excluding technologies through a complex process. The process was revisited and has been … ER -